Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Price competition saves drug money

Media Release

Price competition saves drug money

PHARMAC says a vigorous competitive market in New Zealand has halved the price of a costly anti-ulcer drug over the past three years.

Chief Executive Officer Wayne McNee says the supplier of pantoprazole (Somac) has just reduced its price to the newly agreed price of its competitor omeprazole (Losec).

The drugs, called proton pump inhibitors, are used to treat severe acid stomach problems.

“These drugs are still costly, but competitive pressures mean the taxpayer will now pay $1 a day per patient for them instead of the $2 a day in 1998.”

Earlier this month pharmaceutical company AstraZeneca reached an agreement with PHARMAC, which lowered the price of omeprazole and it regained its status as a fully subsidised medicine.

Now Pharmacia, the supplier of pantoprazole, has matched the lower price.

Wayne McNee says the result is very good news for patients, doctors and the taxpayer.

“Patients have always had access to an effective fully funded treatment, but these latest agreements will give them a choice.”

[ends]

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Elsewhere:


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>